Factoring Project of SINOPHARM Settles in Tianjin Dongjiang, with the Registered Capital of 100 Million Yuan

2017-12-22 10:53

On December 18, the reporter learns from Management Committee of Tianjin Dongjiang that the factoring project of China National Pharmaceutical Group Corporation——SINOPARM Piaoxin Business Factoring Co., Ltd is founded in Dongjiang. A large pharmaceutical group factoring project is also settled in Dongjiang after TaslyHolding Group and Shanghai Pharmaceuticals Holding Co., Ltd. SINOPARM Piaoxin Business Factoring Co., Ltd is set by the wholly owned subsidiary of China National Pharmaceutical Group Corporation——China National Pharmaceutical Investments Co., Ltd, with the registered capital is 100 million Yuan.

China National Pharmaceutical Group Corporationis a large medical health industry group which is directly managed by State-owned Assets Supervision and Administration Commission of the State Council, and a big health whole industrial chain by integrating R&D, manufacturing, logistics distribution, retail chain, medical health, engineering technical services and professional exhibition. It owns 720 subsidiaries and 6 listed companies including SINOPHARM, China National Medicines Co., Ltd, China National Accord Medicines Corporation Ltd, Beijing Tiantan Biological Products Co., Ltd, Shanghai Shyndec Pharmaceutical Co.,Ltd and China Traditional Chinese Medicine Holdings Co., Ltd, which is the unique Chinese pharmaceutical enterprise which enters global 500, and ranks 199 in the list of 2017 global 500.

China National Pharmaceutical Investments Co., Ltd(formerly China Pharmaceutical Industry Company), is the wholly-owned investment and financing company of SINOPHARM,which takes the "based on industry, servegroup" as the basic orientationand aims at promoting the industry and finance and industrial investment and financing services.The establishment of Piaoxin Factoring is the important measure of its investment layout and the financial sector.Next, Piaoxin Factoring will, upon the pharmaceutical industry advantage of the group, with the help of financial innovation policy and good industrial development environment of Dongjiang bonded port area, carry out factoring businesses within the group and upstream and downstream enterprises, and plan to build the advantage brand of Piaoxin Factoring in the field of pharmaceutical big health within 3-5 years.

津滨网版权所有,未经书面授权禁止使用 违法和不良信息举报电话: 022-25204288 022-66336151 服务邮箱:jinbinwang2015@163.com
互联网新闻信息服务许可证:1212016001 备案序号:津ICP备11000547号津公网安备 12010702000020号